Searched for
GLENMARK LICENSING AGREEMENT
Glenmark Pharma will turn cash positive with AbbVie's licensing deal: S&PS&P Global Ratings projects Glenmark Pharmaceuticals will achieve a net cash positive position following its licensing agreement with AbbVi...- Motilal Oswal sees 28% upside in Glenmark Pharma, hails $700 mln cancer drug deal as ‘new era’ for innovation playGlenmark Pharma shares: The brokerage noted that the agreement—executed through Glenmark’s subsidiary, Ichnos Glenmark Innovation (IGI)—“va...
- Glenmark inks licensing pact with Jiangsu Alphamab, 3D Medicines for cancer drugGlenmark Pharmaceuticals Ltd announced that its subsidiary, Glenmark Specialty S A (GSSA), has entered into a license agreement with Jiangs...
- Glenmark Pharma inks exclusive licensing agreement with Lotus InternationalGlenmark will receive an upfront payment as well as regulatory and sales-based milestone payments from Lotus, it added.
- Glenmark looks to license out second drug assetGlenmark chairman and managing director Glenn Saldanha said one of the corporate objectives of the Mumbai-headquartered company is to do at...
- Glenmark inks pact with Menarini Group to commercialise nasal spray in EuropeGlenmark Specialty, a Switzerland-based unit of the company, has entered into an exclusive licensing agreement with the Menarini Group for ...
- Glenmark gets approval from Australian regulator to commercialise RyaltrisGlenmark is entitled to receive commercial milestone payments from Seqirus.
- Glenmark inks licensing pact for generic Tiotropium Bromide dry powder inhaler in Western EuropeThis is the second inhalation product in-licensed by Glenmark for the European market after Fluticasone/Salmeterol dry powder inhaler, the ...
- Glenmark, APC Therapeutics ink licensing pact for cancer drugUnder the terms of the agreement, Glenmark will license the product from APC Therapeutics and manage all clinical development, including re...
- Glenmark Pharmaceuticals inks pact with Celon for generic Seretide AccuhalerAs per the agreement, Glenmark has obtained semi-exclusive marketing and distribution rights of the product across 15 European countries
- Glenmark inks drug development pact with Forest LaboratoriesAs part of the agreement, Glenmark will receive up to $ 9 million (around Rs 50 crore) from US-based Forest Laboratories Inc.
- Glenmark gets DCGI nod for phase III trials of diarrhoea drugGlenmark Pharmaceuticals today said it has received approval from Drug Controller General of India (DCGI) to conduct phase III trials for C...
- Glenmark settles patent suit in US over skin infection creamGlenmark Pharma said it has entered into a agreement with Triax and Astellas to resolve a patent infringement case in the US.
- Glenmark settles patent suit for skin lotion with NycomedFluticasone propionate 0.05 per cent lotion by Glenmark is generic version of Nycomed's 'Cultivate' lotion.
- Glenmark inks pact with Canadian firm for anti-aging productsGlenmark Pharmaceuticals COO Arvind Vasudeva said the association would enable the firm to consolidate its leadership position in dermatolo...
- Glenmark inks licence, supply pact with TaroGlenmark Pharmaceuticals on Thursday said it has signed a licence and supply agreement with Israeli firm Taro Pharmaceuticals to sell a bra...
- Glenmark inks $325-mn licensing deal with SanofiGlenmark Pharmaceuticals licensed its chronic pain molecule to Sanofi Aventis for an upfront payment of $20 million (approximately Rs 89 cr...
- Glenmark surges 12% on BSE on Sanofi-Aventis licensing pactShares of pharma firm Glenmark Pharmaceuticals today vaulted by 12 per cent on the Bombay Stock Exchange to touch a year-high of Rs 303.80 ...
- Dyax Corp, Glenmark ink research agreementGlenmark Pharmaceuticals SA and Dyax Corp has said they have entered into a funded research agreement for the discovery of therapeutic anti...
- Glenmark's US arm in $27m-deal with Paul CapitalThe US subsidiary of Glenmark Pharmaceuticals (Glenmark) has signed a $27m deal with Paul Capital Partners’ Royalty Fund.
Load More
